Internal Medicine · Athens, GA
NPI
1285164368
Since 2017
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1500 Oglethorpe Ave Ste 3600
Athens, GA, 30606
Phone (706) 316-2690
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
896 services
Medicare patients, 2024
261
Average age 72
Drug cost, 2024
$2.1M
3,197 prescriptions
Company payments, 2025
$456
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raghda Al Anbari was code 99214 (office e&m - established), 417 times for 202 patients. In total Raghda Al Anbari billed 896 services in 12 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 417 | 202 | $88.76 | $37K |
| 95251 Test - Miscellaneous | Office | 169 | 67 | $25.37 | $4,288 |
| 83036 Blood Count | Office | 150 | 81 | $9.47 | $1,421 |
| 99204 Office E&M - New | Office | 79 | 79 | $107.79 | $8,516 |
| 99205 Office E&M - New | Office | 26 | 26 | $147.98 | $3,847 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 16 | $12.72 | $242 |
| 99213 Office E&M - Established | Office | 18 | 15 | $59.24 | $1,066 |
By year: 2022 $11K for 98 services; 2023 $45K for 633 services; 2024 $58K for 896 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 150 | 81 | $9.47 | $1,421 |
Medicare prescription drug claims, 2024
In 2024, the drug Raghda Al Anbari prescribed most often to Medicare patients was Levothyroxine Sodium, with 277 prescriptions and refills. In total Raghda Al Anbari wrote 3,197 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 277 | 764 | 89 | $3,006 |
| Jardiance Empagliflozin | 246 | 499 | 72 | $290K |
| Mounjaro Tirzepatide | 246 | 333 | 52 | $350K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 172 | 218 | 35 | $148K |
| Ozempic Semaglutide | 135 | 278 | 47 | $271K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 128 | 306 | 49 | $20K |
| Metformin Hcl Generic | 96 | 266 | 35 | $714 |
| Novolog Flexpen Insulin Aspart | 95 | 154 | 32 | $21K |
| Alendronate Sodium Generic | 92 | 253 | 37 | $937 |
| Trulicity Dulaglutide | 81 | 104 | 17 | $101K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 65 | 149 | 31 | $9,391 |
| Farxiga Dapagliflozin Propanediol | 65 | 125 | 22 | $70K |
| Methimazole Generic | 59 | 146 | 22 | $939 |
| Glipizide Generic | 49 | 115 | 14 | $765 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 48 | 98 | 11 | $47K |
Brand drugs: 1,860 claims; generic drugs: 974 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raghda Al Anbari $456 ($456 in general payments such as food, travel and fees) from 14 companies. The largest payer was Amgen Inc. with $96.34.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 4 | $96.34 |
| Xeris Pharmaceuticals, Inc. | 2 | $43.94 |
| Mannkind Corporation MNKD | 1 | $42.5 |
| Medtronic, Inc. MDT | 2 | $38.27 |
| Novo Nordisk Inc NVO | 2 | $34.01 |
| Radius Health, Inc. | 1 | $32.54 |
| Corcept Therapeutics CORT | 1 | $31.12 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $24.77 |
| CeQur Corporation | 1 | $23.37 |
| Beta Bionics, Inc. BBNX | 2 | $22.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.